TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2647294

Group type: EXPERIMENTAL
Intervention: alpha 2b-interferon with indomethacin
Number of subjects: 53

Group type: COMPARATOR
Intervention: alpha 2b-interferon without indomethacin
Number of subjects: 53
Study: 29761211

Group type: EXPERIMENTAL
Intervention: UMA Jeunesse Ultra® (UJU)
Number of subjects: 75

Group type: COMPARATOR
Intervention: UMA Jeunesse Classic® (UJ)
Number of subjects: 75
Study: 28780563

Group type: EXPERIMENTAL
Intervention: Multi-modal support service programme including mail-delivered cognitive behavioural therapy, telephone-delivered group counselling, and education on community services/resources.
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Multi-modal support service programme.
Number of subjects: 360

Group type: COMPARATOR
Intervention: Wait-list control group.
Number of subjects: 360
Study: 26505201

Group type: EXPERIMENTAL
Intervention: Yoga program (60-minute session twice a week for 8 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no yoga practice, maintain usual physical activity)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Yoga program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 24565712

Group type: EXPERIMENTAL
Intervention: FENO-guided treatment
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 187
Study: 21546164

Group type: EXPERIMENTAL
Intervention: Oxytocin (40 IU intranasal)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 27
Study: 18463442

Group type: EXPERIMENTAL
Intervention: Pentagastrin (6 microg/kg) during placebo treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Omeprazole (40 mg bid) treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Omeprazole treatment
Number of subjects: 19
Study: 16271414

Group type: EXPERIMENTAL
Intervention: Probiotic strains Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard yogurt (control)
Number of subjects: 30
Study: 15345738

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (800 mg/day) combined with testosterone injections (100 mg/week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (800 mg/day) combined with placebo injections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (800 mg/day) combined with resistance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (800 mg/day) combined with resistance training and testosterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo injections)
Number of subjects: 0
Study: 10646150

Group type: EXPERIMENTAL
Intervention: Extracapsular cataract extraction (ECCE)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 55
Study: 9071805

Group type: EXPERIMENTAL
Intervention: Experimental stimuli (combinations of corn syrup and water with viscosities ranging from 2 to 2,240 cP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anchor stimuli representing the extremes of the range of viscosities
Number of subjects: 20
Study: 8365017

Group type: EXPERIMENTAL
Intervention: Early OME diagnosed by tympanometric screens and assessed by language tests at pre-school age.
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Language, reading, and spelling tests conducted at school age.
Number of subjects: 47
Study: 2429334

Group type: EXPERIMENTAL
Intervention: 300 mg tiropramide per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1200 mg imecromone per day
Number of subjects: 40
Study: 31340206

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant Chemoradiation Therapy (NACRT)
Number of subjects: 5371

Group type: COMPARATOR
Intervention: Neo-adjuvant Chemotherapy (NAC)
Number of subjects: 5371

Group type: EXPERIMENTAL
Intervention: NACRT
Number of subjects: 5371

Group type: COMPARATOR
Intervention: NAC
Number of subjects: 5371
Study: 29784257

Group type: EXPERIMENTAL
Intervention: Patient empowerment (provision of detailed information booklet and patient diary)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Patient empowerment
Number of subjects: 91
Study: 27678438

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (3 g/day) with a low-calorie diet
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (3 g/day) with a low-calorie diet
Number of subjects: 90
Study: 24891946

Group type: EXPERIMENTAL
Intervention: Binge eating behavior reported at baseline, 12 months, and 24 months.
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Binge eating behavior across the study period (presence or absence at each time point).
Number of subjects: 419

Group type: COMPARATOR
Intervention: Weight regain rates between those who reported binge eating and those who did not.
Number of subjects: 419
Study: 21937526

Group type: EXPERIMENTAL
Intervention: Posture corrective exercise programme in addition to ultrasound and infrared radiation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Ultrasound and infrared radiation
Number of subjects: 96
Study: 20235203

Group type: EXPERIMENTAL
Intervention: Varicella vaccine (VV)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (healthy children and adolescents)
Number of subjects: 25
Study: 18514633

Group type: EXPERIMENTAL
Intervention: Amino acids (AAs) supplementation, 70.6 kcal/day (8 g of AA snacks) given at 10.00 am and 5.00 pm
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 15885167

Group type: EXPERIMENTAL
Intervention: Rhubarb administration before operation and at 1 day and 2 days after operation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Rhubarb administration
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no rhubarb administration)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups received an isocaloric and isonitrogenous enteral diet
Number of subjects: 31
Study: 11952024

Group type: EXPERIMENTAL
Intervention: Emedastine difumarate 0.05% ophthalmic solution
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ketotifen fumarate 0.025% ophthalmic solution
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 45
Study: 9925236

Group type: EXPERIMENTAL
Intervention: alpha-dihydroergocryptine
Number of subjects: 68

Group type: COMPARATOR
Intervention: lisuride
Number of subjects: 68
Study: 7473999

Group type: EXPERIMENTAL
Intervention: Permissive hypercapnia (PH)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 39
Study: 2277475

Group type: EXPERIMENTAL
Intervention: Streptokinase (1,000,000 units intravenously) followed by intravenous heparin for 5-7 days
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no streptokinase treatment)
Number of subjects: 153
Study: 396083

Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 0
Study: 30777957

Group type: EXPERIMENTAL
Intervention: Single bolus dose of intravenous cefazolin 1 g at surgery (Group A)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Oral cephalexin 500 mg postoperatively twice a day for 5 days (Group B)
Number of subjects: 338
Study: 28351359

Group type: EXPERIMENTAL
Intervention: Training by teaching associates who provided direct feedback on student performance
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group: lessons by an instructor and peer‐based practical skills training
Number of subjects: 181
Study: 25487172

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 24499061

Group type: EXPERIMENTAL
Intervention: Laparoscopic incisional hernia repair
Number of subjects: 270

Group type: COMPARATOR
Intervention: Open incisional hernia repair
Number of subjects: 270
Study: 21372561

Group type: EXPERIMENTAL
Intervention: Gentamicin/heparin (group A)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Taurolidine/citrate (group B)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Heparin (group C)
Number of subjects: 119
Study: 19661450

Group type: EXPERIMENTAL
Intervention: Breathing hypoxic gas (Fi(O2) = 0.12)
Number of subjects: 12
Study: 17264338

Group type: EXPERIMENTAL
Intervention: Oral uracil/ftorafur (UFT) plus leucovorin (LV)
Number of subjects: 1608

Group type: COMPARATOR
Intervention: Intravenous fluorouracil (FU) plus leucovorin (LV)
Number of subjects: 1608
Study: 14979748

Group type: EXPERIMENTAL
Intervention: Visuospatial pattern tapping task during film viewing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal distraction task during film viewing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in state dissociation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in heart rate during the film
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recall and recognition measures
Number of subjects: 0
Study: 11377926

Group type: EXPERIMENTAL
Intervention: Bupropion sustained release
Number of subjects: 248

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 248
Study: 9233710

Group type: EXPERIMENTAL
Intervention: pp65 antigenemia-guided early ganciclovir treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: ganciclovir at engraftment
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: plasma PCR
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: PBL PCR
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: pp65 antigenemia assay
Number of subjects: 29
Study: 8013155

Group type: EXPERIMENTAL
Intervention: Neoadjuvant combination therapy with flutamide and Lupron for 3 months
Number of subjects: 142

Group type: COMPARATOR
Intervention: Prostatectomy alone
Number of subjects: 142
Study: 3626867

Group type: EXPERIMENTAL
Intervention: 200 micrograms Cr + 100 mg nicotinic acid
Number of subjects: 16

Group type: COMPARATOR
Intervention: 200 micrograms Cr
Number of subjects: 16

Group type: COMPARATOR
Intervention: 100 mg nicotinic acid
Number of subjects: 16
Study: 2789777

Group type: EXPERIMENTAL
Intervention: Myringotomy with tympanostomy tube insertion
Number of subjects: 109

Group type: COMPARATOR
Intervention: Myringotomy alone
Number of subjects: 109

Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 109
Study: 30758314

Group type: EXPERIMENTAL
Intervention: P-RDW ratio
Number of subjects: 70
Study: 28207680

Group type: EXPERIMENTAL
Intervention: Participatory randomized controlled trial intervention with eight family skill building sessions
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 352
Study: 25189602

Group type: EXPERIMENTAL
Intervention: Right Ventricular Apical (RVA) pacing
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Right Ventricular High Septal (RVHS) pacing
Number of subjects: 240

Group type: COMPARATOR
Intervention: RVA pacing
Number of subjects: 240

Group type: COMPARATOR
Intervention: RVHS pacing
Number of subjects: 240
Study: 23570475

Group type: EXPERIMENTAL
Intervention: Primary closure after incision and drainage (I&D)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Secondary closure after incision and drainage (I&D)
Number of subjects: 56
Study: 21546629

Group type: EXPERIMENTAL
Intervention: CEM‐102 loading‐dose regimen (1500 mg twice per day on day 1 followed by 600 mg twice per day)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Linezolid (600 mg twice per day)
Number of subjects: 198
Study: 19558888

Group type: EXPERIMENTAL
Intervention: Emulsion of activated-carbon particles injected into the thyroid gland of trial group patients.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned).
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trial group with activated-carbon particles.
Number of subjects: 36
Study: 16434580

Group type: EXPERIMENTAL
Intervention: Financial incentives ($20 for each class attended and $100 if they quit smoking 30 days post program completion)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 179
Study: 14762698

Group type: EXPERIMENTAL
Intervention: FDG-PET after neoadjuvant radiochemotherapy (RCT) with combined regional hyperthermia (RHT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: FDG-PET
Number of subjects: 22
Study: 11225511

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapy
Number of subjects: 0
Study: 9029449

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) + 2.5 mg chlorhexidine (CHX)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 118
Study: 8333480

Group type: EXPERIMENTAL
Intervention: Membrane stripping
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 3552680

Group type: EXPERIMENTAL
Intervention: Verapamil 80 mg tds
Number of subjects: 12

Group type: COMPARATOR
Intervention: Verapamil 40 mg tds
Number of subjects: 12

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Verapamil (higher doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Other side effects
Number of subjects: 12
Study: 31646469

Group type: EXPERIMENTAL
Intervention: Automated motion correction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Manual motion correction with manual review and adjustment
Number of subjects: 100
Study: 31025578

Group type: EXPERIMENTAL
Intervention: pTURP + ADT
Number of subjects: 188

Group type: COMPARATOR
Intervention: ADT
Number of subjects: 188
Study: 28431547

Group type: EXPERIMENTAL
Intervention: Squire's Quest II serious game intervention
Number of subjects: 400
Study: 26310363

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral interventions
Number of subjects: 81
Study: 22999988

Group type: EXPERIMENTAL
Intervention: Exposed to SRIs
Number of subjects: 67

Group type: COMPARATOR
Intervention: Unexposed to SRIs
Number of subjects: 67
Study: 21353251

Group type: EXPERIMENTAL
Intervention: Left atrial volume index ≥40 mL/m²
Number of subjects: 119

Group type: COMPARATOR
Intervention: Left atrial volume index <40 mL/m²
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Preoperative increased E/e' ratio and left ventricular hypertrophy
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: E/e' ratio
Number of subjects: 119
Study: 19039965

Group type: EXPERIMENTAL
Intervention: Propofol (target controlled infusion; 2-3 mcg x ml(‐1))
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sevoflurane (end‐tidal concentration 1‐2%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 50
Study: 16520560

Group type: EXPERIMENTAL
Intervention: Foot reflexion massage (12 sessions, 30 minutes each)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 12689610

Group type: EXPERIMENTAL
Intervention: Intranasal administration of 50 nmol of Neuropeptide Y (NPY)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 10513708

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 1 g/kg daily on 2 consecutive days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plasma exchange (five single-volume exchanges over 2 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (saline solution given in the same manner as IVIG)
Number of subjects: 30
Study: 7575046

Group type: EXPERIMENTAL
Intervention: Personal advice and encouragement from physicians during a single routine consultation
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Supplementary interventions (follow-up letters or visits, demonstration of spirometry, etc.)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Behavior modification techniques (relaxation, rewards and punishment, avoiding 'trigger' situations, etc.)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Sudden cessation or gradual reduction in smoking
Number of subjects: 188
Study: 1794805

Group type: EXPERIMENTAL
Intervention: Epikeratophakia
Number of subjects: 25

Group type: COMPARATOR
Intervention: Penetrating keratoplasty
Number of subjects: 25
Study: 6754131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study: 31101662

Group type: EXPERIMENTAL
Intervention: NeoTapAS (mobile application for heart rate assessment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mental computation (control)
Number of subjects: 60
Study: 29580277

Group type: EXPERIMENTAL
Intervention: Supply on demand distribution strategy
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Unsolicited supply distribution strategy
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Both distribution methods
Number of subjects: 2000
Study: 27578972

Group type: EXPERIMENTAL
Intervention: Home-based spirometry measurements during fluticasone propionate withdrawal over 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-clinic spirometry measurements during fluticasone propionate withdrawal over 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home-based spirometry measurements during continued fluticasone propionate treatment for 52 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-clinic spirometry measurements during continued fluticasone propionate treatment for 52 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based spirometry measurements
Number of subjects: 0
Study: 24952289

Group type: EXPERIMENTAL
Intervention: SMS reminder
Number of subjects: 502

Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 502
Study: 22124939

Group type: EXPERIMENTAL
Intervention: Strong African American Families-Teen (SAAF-T) program
Number of subjects: 502

Group type: COMPARATOR
Intervention: Attention-control program focused on health and nutrition
Number of subjects: 502
Study: 19320650

Group type: EXPERIMENTAL
Intervention: Oral calcium tolerance test (OCTT) with a 10-mmol calcium dose
Number of subjects: 11

Group type: COMPARATOR
Intervention: Dual stable isotope method
Number of subjects: 11
Study: 18414202

Group type: EXPERIMENTAL
Intervention: PNKP T5644G variant allele
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary components
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16053953

Group type: EXPERIMENTAL
Intervention: Eplerenone 25 mg/day
Number of subjects: 0
Study: 12493339

Group type: EXPERIMENTAL
Intervention: Cilomilast (10 mg twice daily) plus nebulised salbutamol (2.5 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cilomilast (10 mg twice daily) plus nebulised placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo plus nebulised salbutamol (2.5 mg)
Number of subjects: 13
Study: 11813717

Group type: EXPERIMENTAL
Intervention: Zinc phosphate cement
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 30

Group type: COMPARATOR
Intervention: Polycarboxylate cement
Number of subjects: 30
Study: 7659146

Group type: EXPERIMENTAL
Intervention: Trimethoprim 80 mg-sulfamethoxazole 400 mg (TMP-SMX) orally twice per day for one month
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trimethoprim 80 mg-sulfamethoxazole 400 mg (TMP-SMX) orally twice per day for one month + frequent ejaculation (at least once every three days) for one month
Number of subjects: 48

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 48
Study: 2576255

Group type: EXPERIMENTAL
Intervention: gestodene (GTD) + ethinyl estradiol (EE)
Number of subjects: 762

Group type: COMPARATOR
Intervention: desogestrel (DSG) + ethinyl estradiol (EE)
Number of subjects: 762
Study: 1270775

Group type: EXPERIMENTAL
Intervention: Professional oral hygiene therapy three times weekly for 5 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 23
Study: 31688909

Group type: EXPERIMENTAL
Intervention: 4-session intervention delivered by an occupational therapist (1 session per month)
Number of subjects: 60
Study: 31307501

Group type: EXPERIMENTAL
Intervention: LED-RL at 160 J/cm2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LED-RL at 320 J/cm2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LED-RL at 480 J/cm2
Number of subjects: 30

Group type: COMPARATOR
Intervention: Temperature-matched mock irradiation (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LED-RL (all doses)
Number of subjects: 30
Study: 29023331

Group type: COMPARATOR
Intervention: Plyometric training on stable surfaces (PTS)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined plyometric training on stable and unstable surfaces (PTC)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both PTS and PTC
Number of subjects: 33
Study: 24766525

Group type: EXPERIMENTAL
Intervention: Face-to-face counseling
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Telephone-based counseling
Number of subjects: 46
Study: 23485539

Group type: EXPERIMENTAL
Intervention: Low dose of daclizumab (1 mg/kg) before and 14 days after transplantation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard treatment protocol only
Number of subjects: 120
Study: 21644317

Group type: EXPERIMENTAL
Intervention: Santong tuina therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional tuina therapy
Number of subjects: 120
Study: 19250106

Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2.0-3.5)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 17026489

Group type: EXPERIMENTAL
Intervention: RSG/MET fixed-dose combination therapy (initial dose 2 mg/500 mg, uptitrated to 8 mg/2000 mg)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: RSG/MET fixed-dose combination therapy
Number of subjects: 468

Group type: COMPARATOR
Intervention: MET monotherapy (initial dose 500 mg, uptitrated to 2000 mg)
Number of subjects: 468

Group type: COMPARATOR
Intervention: RSG monotherapy (initial dose 4 mg, uptitrated to 8 mg)
Number of subjects: 468
Study: 15576973

Group type: EXPERIMENTAL
Intervention: Raloxifene (SERM)
Number of subjects: 0